Insights into structure, stability, and toxicity of monomeric and aggregated polyglutamine models from molecular dynamics simulations
- PMID: 18234827
- PMCID: PMC2367175
- DOI: 10.1529/biophysj.107.118935
Insights into structure, stability, and toxicity of monomeric and aggregated polyglutamine models from molecular dynamics simulations
Abstract
Nine genetically inherited neurodegenerative diseases are linked to abnormal expansions of a polyglutamine (polyQ) encoding region. Over the years, several structural models for polyQ regions have been proposed and confuted. The cross-beta-spine steric zipper motif, identified recently for the GNNQQNY peptide, represents an attractive model for amyloid fibers formed by polyQ fragments. Here we report a detailed molecular dynamics investigation of polyQ models assembled by cross-beta-spine steric zipper motifs. Our simulations indicate clearly that these assemblies are very stable. Glutamine side chains contribute strongly to the overall stability of the models by fitting perfectly within the zipper. In contrast to GNNQQNY zipper motifs, hydrogen bonding interactions provide a significant contribution to the overall stability of polyQ models. Molecular dynamics simulations carried out on monomeric polyQ forms (composed by 40-60 residues) show clearly that they can also assume structures stabilized by steric zipper motifs. Based on these findings, we build monomeric polyQ models that can explain recent data on the toxicity exerted by these species. In a more general context, our data suggests that polyQ models with interdigitated side chains can provide a structural rationale to several literature experiments on polyQ formation, stability, and toxicity.
Figures
Similar articles
-
Dynamics and stability of amyloid-like steric zipper assemblies with hydrophobic dry interfaces.Biopolymers. 2009 Dec;91(12):1161-71. doi: 10.1002/bip.21182. Biopolymers. 2009. PMID: 19280623
-
Insights into stability and toxicity of amyloid-like oligomers by replica exchange molecular dynamics analyses.Biophys J. 2008 Aug;95(4):1965-73. doi: 10.1529/biophysj.108.129213. Epub 2008 May 9. Biophys J. 2008. PMID: 18469082 Free PMC article.
-
Pathologic polyglutamine aggregation begins with a self-poisoning polymer crystal.Elife. 2023 Nov 3;12:RP86939. doi: 10.7554/eLife.86939. Elife. 2023. PMID: 37921648 Free PMC article.
-
Physical chemistry of polyglutamine: intriguing tales of a monotonous sequence.J Mol Biol. 2012 Aug 24;421(4-5):466-90. doi: 10.1016/j.jmb.2012.01.030. Epub 2012 Jan 27. J Mol Biol. 2012. PMID: 22306404 Free PMC article. Review.
-
Understanding amyloid fibril nucleation and aβ oligomer/drug interactions from computer simulations.Acc Chem Res. 2014 Feb 18;47(2):603-11. doi: 10.1021/ar4002075. Epub 2013 Dec 24. Acc Chem Res. 2014. PMID: 24368046 Review.
Cited by
-
Structural characterization of GNNQQNY amyloid fibrils by magic angle spinning NMR.Biochemistry. 2010 Nov 9;49(44):9457-69. doi: 10.1021/bi100077x. Biochemistry. 2010. PMID: 20695483 Free PMC article.
-
Thermodynamic description of polymorphism in Q- and N-rich peptide aggregates revealed by atomistic simulation.Biophys J. 2009 Jul 8;97(1):1-11. doi: 10.1016/j.bpj.2009.03.062. Biophys J. 2009. PMID: 19580739 Free PMC article.
-
Assessing the contribution of heterogeneous distributions of oligomers to aggregation mechanisms of polyglutamine peptides.Biophys Chem. 2011 Nov;159(1):14-23. doi: 10.1016/j.bpc.2011.04.006. Epub 2011 Apr 12. Biophys Chem. 2011. PMID: 21530061 Free PMC article.
-
Chaperone-like N-methyl peptide inhibitors of polyglutamine aggregation.Biochemistry. 2010 Aug 24;49(33):7108-18. doi: 10.1021/bi1006095. Biochemistry. 2010. PMID: 20583779 Free PMC article.
-
Amyloid-Like Aggregation in Diseases and Biomaterials: Osmosis of Structural Information.Front Bioeng Biotechnol. 2021 Mar 3;9:641372. doi: 10.3389/fbioe.2021.641372. eCollection 2021. Front Bioeng Biotechnol. 2021. PMID: 33748087 Free PMC article. Review.
References
-
- Chiti, F., and C. M. Dobson. 2006. Protein misfolding, functional amyloid, and human disease. Annu. Rev. Biochem. 75:333–366. - PubMed
-
- Buxbaum, J. N. 2003. Diseases of protein conformation: what do in vitro experiments tell us about in vivo diseases? Trends Biochem. Sci. 28:585–592. - PubMed
-
- Ross, C. A., and M. A. Poirier. 2004. Protein aggregation and neurodegenerative disease. Nat. Med. 10(Suppl):S10–S17. - PubMed
-
- Carrell, R. W. 2005. Cell toxicity and conformational disease. Trends Cell Biol. 15:574–580. - PubMed
-
- Kayed, R., E. Head, J. L. Thompson, T. M. McIntire, S. C. Milton, C. W. Cotman, and C. G. Glabe. 2003. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science. 300:486–489. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
